HER2 Biomarkers
News and reporting on HER2 biomarkers.
Real-World Data Show 72 Percent of Bladder Cancer Patients Got Genomic Testing in Community Network
Premium
The analysis by Ontada tracked testing rates within the US Oncology Network for PD-L1, FGFR2/3, and HER2 biomarkers over 10 years.
Marengo Begins Phase Ib/II Trial of Invikafusp Alfa, Trodelvy in Certain Breast Cancers
The study will include two cohorts of breast cancer patients: triple-negative breast cancer and HR-positive, HER2-negative breast cancer.
AstraZeneca to Discuss Neoadjuvant Enhertu Regimen With Regulators Following Early Data Readout
Patients on Enhertu followed by a chemotherapy and dual anti-HER2 regimen fared better than those on standard therapy.
In a Phase I study presented at AACR's annual meeting, 71 percent of patients who hadn't received a prior anti-HER2 ADC responded to the drug.
CHMP Issues Positive Recommendation for Jazz Pharmaceuticals' Ziihera
If the European Commission approves this treatment, it'll be the first HER2-targeted agent for HER2-positive biliary tract cancer available to patients in the EU.
Jan 30, 2025